Dutch refine use of PET to predict cancer therapy outcome
December 20, 2019 -- Researchers from the Netherlands are edging closer to proving the value of zirconium-89 immuno-PET as a noninvasive approach to predicting the effectiveness of therapy for cancerous tumors. Their findings have appeared in the December edition of the Journal of Nuclear Medicine.  Discuss
AI-assisted FDG-PET/CT advances lung nodule detection
December 16, 2019 -- Swiss investigators have developed an artificial intelligence (AI) algorithm that could become a valuable tool for detecting small, FDG-avid pulmonary nodules on oncologic PET/CT scans, according to a study published online on 10 December in European Radiology.  Discuss
Novel therapy brings hope in neuroendocrine tumors
December 16, 2019 -- Award-winning researchers from a top London facility have demonstrated how lutetium-177 peptide receptor radionuclide therapy is showing significant promise in the treatment of patients with inoperable or metastasized neuroendocrine tumors.  Discuss
PET/MRI wins support in breast lesion comparisons
December 16, 2019 -- Researchers from the University of Düsseldorf in Germany have found that the combination of PET with MRI was statistically superior to MRI alone for normal detection and staging of breast cancer, as well as in the detection of distant metastases (M staging). They revealed their findings at RSNA 2019.  Discuss
German team shows value of FDG-PET/MRI in breast cancer
December 13, 2019 -- A new study from Düsseldorf, Germany, has found that FDG-PET/MRI shows promise for accurate staging of breast cancer, but the modality still isn't as accurate as sentinel lymph node biopsy. The researchers presented their results at RSNA 2019.  Discuss
Is it safe to undergo FDG-PET/CT after cardiac surgery?
December 5, 2019 -- Determining when it's safe for patients to undergo FDG-PET/CT after aortic prosthetic heart valve implantation is a controversial topic. A Dutch study presented on Tuesday at RSNA 2019 found that such a scan within the first 12 months is viable.  Discuss
FDG-PET/CT has limits in esophageal cancer follow-up
November 7, 2019 -- FDG-PET/CT might be considered a double-edged sword when it comes to esophageal cancer. The modality fell short of identifying some higher tumor regression grades, but it detected interval metastases during post-treatment surveillance in a study published in the November issue of the Journal of Nuclear Medicine.  Discuss
PET/MRI illuminates cerebral vascular risk factors
November 6, 2019 -- PET/MRI scans show middle-aged adults with high vascular risk factors have less whole-brain volume by the time they reach their late 60s, but their lifestyle and physical characteristics do not influence beta-amyloid accumulation, according to a study published online on 4 November in JAMA Neurology.  Discuss
IMV: Global radiologists stay positive despite challenges
November 4, 2019 -- Radiologists in global markets are optimistic about future growth prospects for medical imaging procedures, but their priorities for imaging equipment are being dictated by local conditions. That's according to a new market research report by IMV Medical Information Division.  Discuss
German team casts doubt on PET's value in Alzheimer's
October 31, 2019 -- Researchers from a leading German facility have investigated whether a person's progression from mild cognitive impairment to Alzheimer's disease can be reliably predicted without PET imaging. Their study published online on 18 October in the Journal of Nuclear Medicine lists several nonimaging methods that can offer a better prognosis than the modality.  Discuss